Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced today an Illumina-sponsored ...

Preconfigured applications: DRAGEN v4.4 will offer "push-button" analysis for oncology workflows, including the first and ...

Qiagen has a relatively well-diversified portfolio across four segments. Find out my recommendation on QGEN stock here.

This scientific breakthrough holds significant promise for conservation efforts, breeding programs, and a deeper ...

Methods for genomic analysis typically require high-throughput sequencing or microarray hybridization and bioinformatics. New statistical and machine learning techniques to understand, quantify ...

(Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial ...

Osaic, Inc. ("Osaic"), one of the nation's largest providers of wealth management solutions, today announced further expansion of its Osaic Institutions channel through the addition of five new credit ...

Pluto Bio, the leading, AI-powered platform for computational biology, today announced it has raised $3.6 million in new funding to accelerate growth and scale adoption of its enterprise-grade ...

In the rapidly evolving field of genetics, the continuous development of advanced tools and methodologies is revolutionizing ...

FMS-like tyrosine kinase 3 (FLT3) mutations represent some of the most pivotal genetic alterations in acute myeloid leukemia (AML), influencing ...